论文部分内容阅读
目的对某三甲医院甲状腺良性肿物患者进行DRGs分组,探讨甲状腺良性肿物患者的住院费用,为制定相关DRGs组的支付标准提供参考。方法选择某三甲医院2013年1月-2015年10月以甲状腺良性肿物为主要诊断的病例,先采用单因素分析和多元线性逐步回归方法对病案数据进行分析,再利用决策树模型建立甲状腺良性肿物患者的DRGs病例组合模型。结果甲状腺良性肿物患者住院费用的主要影响因素为治疗方式及住院天数;通过分组后,共形成了4个有效DRGs组合和对应住院费用标准,不同分组间的住院费用间的差异有统计学意义(P<0.05)。结论甲状腺良性肿物的DRGs分组综合了治疗方式和住院天数,通过制定符合相应组别的患者住院费用标准,有利于减轻患者的经济负担,可为医疗费用支付方式改革提供参考。
Objective To study the DRGs of patients with benign thyroid tumors in a top three hospital and discuss the cost of hospitalization for patients with benign thyroid tumors and provide references for making the payment criteria for the related DRGs. Methods A case of benign thyroid tumors was diagnosed in a top-grade hospital from January 2013 to October 2015. Uni-factor analysis and multivariate linear step-by-step regression analysis were used to analyze the medical record data. Then the model of benign thyroid gland Combined model of DRGs in patients with tumor. Results The main influencing factors of hospitalization cost of thyroid benign tumor patients were the treatment method and number of days of hospitalization. After the grouping, a total of 4 effective DRGs combinations and corresponding hospitalization costs were formed, and the differences among the hospitalization costs among different groups were statistically significant (P <0.05). Conclusions The DRGs of thyroid benign masses combine the treatment methods and days of hospitalization. By formulating the standard of hospitalization expenses for the patients in the corresponding group, it is helpful to reduce the financial burden on the patients and provide a reference for the reform of the medical expense payment.